Background and Purpose: The use of thrombolytics is frequently mentioned in patients with cerebral venous or dural sinus thrombosis (CVDST) who deteriorate despite anticoagulant therapy. The aim of this review was to collect all the published information about their use in CVDST and to assess their efficacy and safety. Methods: To find cases of CVDST treated with thrombolytics, we performed a MEDLINE search from 1966 to July 2001, checked all reference lists of studies found and hand searched volumes of 11 journals. Data was extracted by means of a standardised data extraction form. Proportions and 95% confidence intervals (CI) were calculated for outcomes and complications of thrombolytics. Cases were stratified according to variables that may influence the outcome and subgroups were compared by odds ratios and 95% CI. Results: No randomised clinical trial (RCT) was found. Seventy-two studies (169 patients) were included. Urokinase was the thrombolytic most frequently administered (76%). In the majority of cases the thrombolytic was locally infused in the occluded sinus (88%). At discharge, 10 cases (7%; 95% CI 3–12%) were dependent and 9 cases (5%; 95% CI 2–9%) died. Intracranial haemorrhages occurred in 17% of cases. In 5% they were associated with clinical deterioration. Extracranial haemorrhages occurred in 21%, but only 2% required blood transfusion. Conclusions: Thrombolytics appeared to be reasonably safe in CVDST, but its efficacy cannot be assessed from the published data. Considering that CVDST is an uncommon disease, a randomised controlled trial to assess effectiveness and safety of local thrombolytics in cases of CVDST with poor prognosis is difficult but not impossible to undertake, on a multicentre international collaboration trial.

Keywords:
Venous thrombosis, Dural sinus, Thrombolysis, Fibrinolysis, Systematic review
1.
Bousser MG, Ross Russell R: Cerebral Venous Thrombosis. London, Saunders, 1997, vol 1.
2.
Canhão P, Barinagarrementeria F, Bousser MG, Ferro J, Stam J: International study on cerebral vein and dural sinus thrombosis (ISCVT). Cerebrovasc Dis 2001;11(suppl 4):1–28.
3.
De Bruijn SFTM, Stam J, for the Cerebral Venous Sinus Thrombosis Group: Randomised placebo-controlled trial of anticoagulant treatment with low molecular weight heparin for cerebral sinus thrombosis. Stroke 1999;30:484–488.
4.
Einhäupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, Habertl RL, Pfister HW, Schmiedek P: Heparin treatment in sinus venous thrombosis. Lancet 1991;338:597–600.
5.
Biller J, Feinberg WM, Castaldo JE, et al: Guidelines for carotid endarterectomy. A statement of healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association and the American Academy of Neurology. Stroke 1998;29:554–562.
6.
Abumiya T, Echizenya K, Ihara T, Satou M: A case of venous thrombosis associated with medullary venous malformation. No Shinkei Geka 1992;20:451–455.
7.
Akai T, Kuwayama N, Ogiichi T, Kurimoto M, Endo S, Takaku A: Leptomeningeal melanoma associated with straight sinus thrombosis – Case report. Neurol Med Chir (Tokyo) 1997;37:757–761.
8.
Aoki N, Uchinuno H, Tanikawa T, Kagawa M, Takakura K: Superior sagittal sinus thrombosis treated with combined local thrombolytic and systemic anticoagulation therapy. Acta Neurochir (Wien) 1997;139:332–335.
9.
Aray T, Ohno K, Yoshino Y, Tanaka Y, Nariai T, Hirakawa K, Nemoto S: Dural arteriovenous fistula involving the superior sagittal and transverse-sigmoid sinus, treated by thrombolysis: Case report. No Shinkei Geka 1997;25:621–626.
10.
Baker MD, Opatowksy MJ, Wilson J, Steven S, Glazier S Morris P: Rheolytic catheter and thrombolysis of dural venous sinus thrombosis. A case series. Neurosurgery 2001;48:487–493.
11.
Barnwell SL, Nesbit GM, Clark WM: Local thrombolytic therapy for cerebrovascular disease: Current Oregon Health Sciences University experience (July 1991 through April 1995). J Vasc Interv Radiol 1995;6:78S–82S.
12.
Buccino G, Scoditti U, Pini M, Menozzi R, Piazza P, Zuccoli P, Mancia D: Loco-regional thrombolysis in the treatment of cerebral venous and sinus thrombosis: Report of two cases. Acta Neurol Scand 2001;103:59–63.
13.
Camacho GDR, Orozco AL, Higueras AP, López MC, Al-Assir I, Ruiz-Moreno M: Moyamoya disease and sagittal sinus thrombosis in a child with Down’s syndrome. Pediatr Radiol 2001;31:125–128.
14.
Campbell RL: Thrombolysis for superior sagittal sinus thrombosis – Invited commentaries. J Vasc Interv Radiol 1991;2:93–94.
15.
Chaloupka JC, Mangla S, Huddle DC: Use of mechanical thrombolysis via microballoon percutaneous transluminal angioplasty for the treatment of acute dural sinus thrombosis: Case presentation and technical report. Neurosurgery 1999;45:650–656.
16.
Chow K, Gobin P, Saver J, Kidwell C, Dong P, Viñuela F: Endovascular treatment of dural sinus thrombosis with rheolytic thrombectomy and intra-arterial thrombolysis. Stroke 2000;31:1420–1425.
17.
D’Alise MD, Fichtel F, Horowitz M: Sagittal sinus thrombosis following minor head injury treated with continuous urokinase infusion. Surg Neurol 1998;49:430–435.
18.
Debrun G: Endovascular treatment of traumatic dural sinus thrombosis: Case report – Comments. Neurosurgery 1998;42:1167.
19.
DiRocco C, Iannelli A, Leone G, Moschini M, Valori VM: Heparin-urokinase treatment in aseptic dural sinus thrombosis. Arch Neurol 1981;38:431–435.
20.
Dowd CF, Malek AM, Phatouros CC, Hemphill JC III: Application of a rheolytic thrombectomy device in the treatment of dural sinus thrombosis: A new technique. AJNR 1999;20:568–570.
21.
Dzialo AF, Black-Schaffer RM: Cerebral venous thrombosis in young adults: Two case reports. Arch Phys Med Rehabil 2001;82:683–688.
22.
Ekseth K, Boström S, Vegfors M: Reversibility of severe sagittal sinus thrombosis with open surgical thrombectomy combined with local infusion of tissue plasminogen activator: Technical case report. Neurosurgery 1998;43:960–964.
23.
Eskridge JM, Wessbecher FW: Thrombolysis for superior sagittal sinus thrombosis. J Vasc Interv Radiol 1991;2:89–93.
24.
Evans MS, Naritoku DK, Couch JR, Ghobrial MW: Onset of neurologic deficits after treatment with dihydroergotamine in a patient with sagittal sinus thrombosis. Clin Neuropharmacol 1996;19:177–184.
25.
Frey JL, Muro GJ, McDougall CG, Dean BL, Jahnke HK: Cerebral venous thrombosis. Combined intrathrombus rtPA and intravenous heparin. Stroke 1999;30:489–494.
26.
Gebara BM, Everett KO: Dural sinus thrombosis complicating hypernatremic dehydration in a breast-fed neonate. Clin Pediatr 2001;40:45–48.
27.
Gebara BM, Goetting MG, Wang AM: Dural sinus thrombosis complicating subclavian vein catheterization: Treatment with local thrombolysis. Pediatrics 1995;95:138–140.
28.
Gerszten PC, Welch WC, Spearman MP, Jungreis CA, Redner RL: Isolated deep cerebral venous thrombosis treated by direct endovascular thrombolysis. Surg Neurol 1997;48:261–266.
29.
Gettelfinger DM, Kokmen E: Superior sagittal sinus thrombosis. Arch Neurol 1977;34:2–6.
30.
Gomez CR, Misra VK, Terry JB, Tulyapronchote R, Campbell MS: Emergency endovascular treatment of cerebral sinus thrombosis with a rheolytic catheter device. J Neuroimaging 2000;10:177–180.
31.
Griesemer DA, Theodorou AA, Berg RA, Spera TD: Local fibrinolysis in cerebral venous thrombosis. Pediatr Neurol 1994;10:78–80.
32.
Gurley MB, King TS, Tsay FY: Sigmoid sinus thrombosis associated with internal jugular venous occlusion: Direct thrombolytic treatment. J Endovasc Surg 1996;3:306–314.
33.
Higashida RT, Helmer E, Halbach VV, Hieshima GB: Direct thrombolytic therapy for superior sagittal thrombosis. AJNR 1989;10:S4–S6.
34.
Holder CA, Bell A, Lundell AL, Ulmer JL, Glazier SS: Isolated straight sinus and deep cerebral venous thrombosis: Successful treatment with local infusion of urokinase. J Neurosurg 1997;86:704–707.
35.
Horowitz M, Purdy P, Unwin H, Carstens G, Greenlee R, Hise J, Kopitnik T, Batjer H, Rollins N, Samson D: Treatment of dural sinus thrombosis using selective catheterization and urokinase. Ann Neurol 1995;38:58–67.
36.
Hourihane JM, Deloughery TG, Clark WM: Homozygous hereditary resistance to activated protein C presenting as cerebral venous thrombosis. J Stroke Cerebrovasc Dis 1997;6:370–372.
37.
Kasner SE, Gurian JH, Grotta JC: Urokinase treatment of sagittal sinus thrombosis with venous hemorrhagic infarction. J Stroke Cerebrovasc Dis 1998;7:421–425.
38.
Kermode AG, Ives FJ, Taylor B, Carroll WM: Progressive dural venous sinus thrombosis treated with local streptokinase infusion. J Neurol Neurosurg Psychiatry 1995;58:107–108.
39.
Khoo KBK, Long FL, Tuck RR, Allen RJ, Tymms KE: Cerebral venous sinus thrombosis associated with the primary antiphospholipid syndrome. Resolution with local thrombolytic therapy. Med J Aust 1995;162:30–32.
40.
Kim SY, Suh JH: Direct endovascular thrombolytic therapy for dural sinus thrombosis: Infusion of alteplase. AJNR 1997;18:639–645.
41.
Kollar C, Parker G, Johnston I: Endovascular treatment of cranial venous sinus obstruction resulting in pseudotumor syndrome. Report of three cases. J Neurosurg 2001;94:646–651.
42.
Kourtopoulos H, Christie M, Rath B: Open thrombectomy combined with thrombolysis in massive intracranial sinus thrombosis. Acta Neurochir (Wien) 1994;128:171–173.
43.
Kuether TA, O’Neill O, Nesbit GM, Barnwell SL: Endovascular treatment of traumatic dural sinus thrombosis: Case report. Neurosurgery 1998;42:1163–1166.
44.
Majoie CB, van Delden OM, Sluzewski M, Nijssen P, Stam J, Reekers JA: Neuroradiologic intervention in two patients with cerebral sinus thrombosis. Ned Tijdschr Geneeskd 2000;144:1839–1844.
45.
Manthous CA, Chen H: Case report: Treatment of superior sagittal sinus thrombosis with urokinase. Conn Med 1992;56:529–530.
46.
Manzione J, Newman GC, Shapiro A, Santo-Ocampo R: Diffusion- and perfusion-weighted MR imaging of dural sinus thrombosis. AJNR 2000;21:68–73.
47.
Medlock MD, Olivero WC, Hanigan WC, Wright RM, Winek SJ: Children with cerebral venous thrombosis diagnosed with magnetic resonance imaging and magnetic resonance angiography. Neurosurgery 1992;31:870–876.
48.
Nagai T, Tomizawa T, Tonooka N, Mita Y, Misumi S, Mori M: Diabetes mellitus with left transverse sinus thrombosis and right transverse sinus aplasia. Diabetes Res Clin Pract 2001;51:39–43.
49.
Nagatomo Y, Yanaka K, Kamezaki T, Kobayashi E, Matsumura A, Nose T: Recovery from primary deep cerebral venous sinus thrombosis with recanalisation. Neuroradiology 1995;37:645–648.
50.
Niwa J, Ohyama H, Matumura S, Maeda Y, Shimizu T: Treatment of acute superior sagittal sinus thrombosis by t-PA infusion via venography – Direct thrombolytic therapy in the acute phase. Surg Neurol 1998;49:425–429.
51.
Novak Z, Coldwell DM, Brega KE: Selective infusion of urokinase and thrombectomy in the treatment of acute cerebral sinus thrombosis. AJNR 2000;21:143–145.
52.
Ohata K, Haque M, Morino M, Nagai K, Nishio A, Nishijima Y, Hakuba A: Occlusion of the sigmoid sinus after surgery via the presigmoidal-transpetrosal approach. J Neurosurg 1998;89:575–584.
53.
Opatowsky MJ, Morris P, Regan JD, Mewborne JD, Wilson JA: Rapid thrombectomy of superior sagittal sinus and transverse sinus thrombosis with a rheolytic catheter device. AJNR 1999;20:414–417.
54.
Ossemann M, Laloux P, Doyen C, Sonnet A, Dive A, Bulpa P, DeCoene B, Ide C: Systemic thrombolysis in cerebral venous thrombosis extended from the jugular vein. Cerebrovasc Dis 2000;10:247–248.
55.
Persson L, Lilja A: Extensive dural sinus thrombosis treated by surgical removal and local streptokinase infusion. Neurosurgery 1990;26:117–121.
56.
Philips MF, Bagley LJ, Sinson GP, Raps EC, Galetta SL, Zager EL, Hurst RW: Endovascular thrombolysis for symptomatic cerebral venous thrombosis. J Neurosurg 1999;90:65–71.
57.
Rael JR, Orrison WW, Baldwin N, Sell J: Direct thrombolysis of superior sagittal sinus thrombosis with coexisting intracranial haemorrhage. AJNR 1997;18:1238–1242.
58.
Rau CS, Lui CC, Liang CL, Chen HJ, Kuo YL, Chen WF: Superior sagittal sinus thrombosis induced by thyrotoxicosis. J Neurosurg 2001;94:130–132.
59.
Renowden SA, Bradshaw JR, Lewis TT: Cerebral venous thrombosis: Local thrombolysis? Neuroradiology 2000;42:224–225.
60.
Renowden SA, Oxbury J, Molyneux AJ: Case report: Venous sinus thrombosis: the use of thrombolysis. Clin Radiol 1997;52:396–399.
61.
Satake R, Arakawa S, Hashimoto M, Minamide H, Takamori M: Successful direct thrombolysis in a patient with extensive dural sinus thrombosis induced by danazol. Rinsho Shinkeigaku 1997;37:309–313.
62.
Scott JA, Pascuzzi RM, Hall PV, Becker GJ: Treatment of dural sinus thrombosis with local urokinase infusion. J Neurosurg 1988;68:284–287.
63.
Smadja D, Raynaud M, Mehdaoui H, Poey C, Drault JN, Ridarch A, Tixier F, Vernant JC, Mas JL: Thrombose veineuse cérébrale étendue résistante à l’héparine: Fibrinolyse locale par urokinase. Rev Neurol (Paris) 1997;153:271–274.
64.
Smith AG, Cornblath WT, Deveikis JP: Local thrombolytic therapy in deep cerebral venous thrombosis. Neurology 1997;48:1613–1619.
65.
Smith TP, Higashida RT, Barnwell SL, Halbach VV, Dowd CF, Fraser KW, Teitelbaum GP, Hieshima GB: Treatment of dural sinus thrombosis by urokinase infusion. AJNR 1994;15:801–807.
66.
Spearman MP, Jungreis CA, Wehner JJ, Gerszten PC, Welch WC: Endovascular thrombolysis in deep cerebral venous thrombosis. AJNR 1997;18:502–506.
67.
Städler C, Vuadens Ph, Dewarrat A, Janzer R, Uske A, Bogousslavsky J: Thrombose veineuse cérébrale après ponction lombaire et stéroïds intraveineux chez deux patients souffrant d’une sclérose en plaques. Rev Neurol (Paris) 2000;156:2,155–159.
68.
Svendsen P, Wikholm G, Lundqvist C, Lundh T, Stephensen H: Superselektiv kateterisering. Behandling av sinustrombos direkt i tromberna. Lakartidningen 1993;90:1957–1959.
69.
Takami T, Suzuki T, Tokuno H, Egashira M, Tsuyuguchi N, Komiyana M, Hakuba A: A case report of dural sinus thrombosis: Direct thrombolytic therapy using endovascular surgery. No Shinkei Geka 1995;23:321–325.
70.
Tsay FY, Higashida RT, Matovich V, Alfieri K: Acute thrombosis of the intracranial dural sinus: Direct thrombolytic treatment. AJNR 1992;13:1137–1141.
71.
Tsay FY, Wang AM, Matovich VB, Lavin M, Berberian B, Simonson TM, Yuh WTC: MR staging of acute dural sinus thrombosis: Correlation with venous pressure measurements and implications for treatment and prognosis. AJNR 1995;16:1021–1029.
72.
Tsujikawa T, Urabe M, Bamba H, Andoh A, Sasaki M, Koyama S, Fujiyama Y, Bamba T: Haemorrhagic cerebral sinus thrombosis associated with ulcerative colitis: A case report of successful treatment by anticoagulant therapy. J Gastroenterol Hepatol 2000;15:688–692.
73.
Vines FS, Davis OD: Clinical-radiological correlation in cerebral venous occlusive disease. Radiology 1971;98:9–22.
74.
Wasay M, Bakshi R, Kojan S, Bobustuc G, Dubey N: Superior sagittal sinus thrombosis due to lithium: Local urokinase thrombolysis treatment. Neurology 2000;54:532–533.
75.
Witham TF, Nemoto EM, Jungreis CA, Kaufmann AM: Near-infrared spectroscopy monitored cerebral venous thrombolysis. Can J Neurol Sci 1999;26:48–52.
76.
Wong VK, LeMesurier J, Franceschini R, Heikali M, Hanson R: Cerebral venous thrombosis as a cause of neonatal seizures. Pediatr Neurol 1987;3:235–237.
77.
Yamini B, Loch Macdonald R, Rosenblum J Treatment of deep cerebral venous thrombosis by local infusion of tissue plasminogen activator. Surg Neurol 2001;55:340–345.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.